IL6R rs9217: Understanding Your Genetic Variant
The rs9217 variant is a common genetic change located within the IL6R gene, which provides instructions for making the interleukin-6 receptor. Research indicates this variant is statistically associated with levels of the soluble IL-6 receptor and may influence inflammatory pathways linked to cardiovascular health.
What each genotype means
Typical receptor expression
This genotype is associated with baseline levels of the soluble interleukin-6 receptor. Research has explored potential links between this variant and inflammatory markers, though findings regarding specific disease risks remain complex and context-dependent.
This is a common genotype found in many global populations.
Typical receptor expression
Individuals with this heterozygous genotype carry one copy of each allele. Studies suggest this variant influences the regulation of the IL-6 receptor, but the clinical significance of this specific combination is not considered a primary driver of disease risk.
This genotype is frequently observed across diverse ancestral groups.
Varied receptor expression
This genotype has been investigated for its potential association with altered levels of the soluble IL-6 receptor. While some studies have looked at its role in inflammatory responses, the evidence is not sufficient to suggest a direct clinical impact on health outcomes.
This genotype is common and widely distributed in human populations.
What is the rs9217 Variant?
The rs9217 variant is a single-nucleotide polymorphism (SNP) located within the IL6R gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found within the genomic region that encodes the interleukin-6 receptor, a protein critical for immune system communication. Because it is a common variant, it is frequently studied in large-scale genome-wide association studies (GWAS) to understand how subtle differences in our genetic code might correlate with biological traits. Scientists track these variants to see if they act as markers for specific physiological processes, such as how the body regulates inflammation or responds to immune signals.
The Role of the IL6R Gene
The IL6R gene encodes the alpha subunit of the interleukin-6 receptor. This receptor is essential for the body's response to interleukin-6 (IL-6), a cytokine that acts as a messenger in the immune system. IL-6 signaling can occur in two ways: 'classic' signaling, which is generally anti-inflammatory and involved in tissue regeneration, and 'trans-signaling,' which is often associated with pro-inflammatory responses. The receptor exists in both a membrane-bound form on the surface of cells and a soluble form that circulates in the blood. By regulating the availability and activity of these receptors, the IL6R gene helps fine-tune the body's inflammatory response, which is a complex process involved in both protecting the body from infection and contributing to chronic disease states if left unchecked.
Research and Evidence Strength
Current research, including data from the GWAS Catalog and various Mendelian randomization studies, suggests a moderate level of evidence linking variants in the IL6R region to inflammatory markers and cardiovascular outcomes. Specifically, studies have observed that genetic variation in this gene can influence the concentration of soluble IL-6 receptors in the blood. Because IL-6 signaling is a key driver of inflammation—often measured by downstream biomarkers like C-reactive protein (CRP)—researchers investigate these variants to understand their potential role in cardiovascular risk. While these statistical associations are robust in large populations, it is important to note that genetic associations do not imply direct causation. The biological impact of a single SNP is often small and works in concert with many other genetic and environmental factors to influence overall health.
Population Frequency
The rs9217 variant is considered a common polymorphism, meaning it is found at a significant frequency across diverse human populations. Because it is common, it is widely represented in genetic databases, allowing researchers to perform large-scale statistical analyses with high confidence in the frequency data. While the exact percentage can vary slightly depending on the ancestral background of the study participants, it is generally present in a large portion of the global population. This high frequency makes it a useful tool for researchers studying the genetic architecture of complex traits, as it provides a large sample size for observing how the variant correlates with specific health-related biomarkers across different groups.
Interpreting Your Genetic Information
Understanding your genotype for rs9217 provides insight into your unique genetic makeup, but it is not a diagnostic tool. Genetic associations identified in research studies describe trends across large groups of people and cannot predict an individual's specific health outcomes. Many factors, including diet, lifestyle, environment, and other genetic variants, play a much larger role in determining your cardiovascular health than any single SNP. If you have concerns about your cardiovascular risk or inflammatory markers, it is essential to consult with a healthcare professional. They can interpret your clinical test results—such as blood pressure, cholesterol, and CRP levels—in the context of your overall health history. Never use genetic information to make decisions about medications or treatments without discussing them with your doctor or a qualified pharmacist.
How common is this variant?
The rs9217 variant is a common genetic polymorphism found across diverse ancestral populations, with its specific genotype frequencies well-documented in large-scale genomic databases.
Frequently asked questions
Is rs9217 a diagnostic test for heart disease?
No, rs9217 is not a diagnostic test. It is a genetic variant associated with biological markers in research studies, but it cannot predict whether an individual will develop heart disease.
Can I change my risk based on my rs9217 genotype?
Your genotype is fixed, but your health is influenced by many modifiable factors. Focus on heart-healthy habits like a balanced diet, regular exercise, and routine medical screenings as recommended by your doctor.
What does the IL6R gene do?
The IL6R gene provides instructions for making the interleukin-6 receptor, which helps regulate the body's immune and inflammatory responses.
Should I take medication based on this result?
No. You should never start, stop, or change any medication based on genetic test results. Always discuss your health and any potential treatments with your clinician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9217?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL6R
A functional missense variant (p.Asp358Ala) in the IL6R gene associated with increased levels of soluble IL-6 receptor and modulation of inflammatory responses.
Synonymous polymorphism in IL6R often studied in the context of inflammatory signaling; however, the primary functional variant in this gene is rs2228145 (Asp358Ala).
An intronic variant in the IL6R gene associated with systemic inflammatory signaling, reduced risk of certain cardiovascular conditions, and parental lifespan.
This SNP is associated with variations in C-reactive protein (CRP) levels and is considered a marker for systemic inflammation and cardiovascular risk.
This variant is a functional polymorphism in the IL6R gene associated with altered levels of soluble interleukin-6 receptor and C-reactive protein, influencing inflammatory response.
Functional missense variant (p.Asp358Ala) that enhances proteolytic shedding of IL-6R to elevate soluble receptor levels while dampening classical IL-6 inflammatory signaling, conferring protection against coronary heart disease.